Published in J Mol Diagn on May 14, 2011
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis (2014) 1.04
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis (2013) 1.02
Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media. J Clin Microbiol (2013) 0.95
Is human papillomavirus associated with prostate cancer survival? Dis Markers (2013) 0.95
Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. J Low Genit Tract Dis (2014) 0.94
Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstet Gynecol (2014) 0.91
Human papillomavirus genotype and oropharynx cancer survival in the United States of America. Eur J Cancer (2015) 0.90
Semi-nested real-time reverse transcription polymerase chain reaction methods for the successful quantitation of cytokeratin mRNA expression levels for the subtyping of non-small-cell lung carcinoma using paraffin-embedded and microdissected lung biopsy specimens. Acta Histochem Cytochem (2013) 0.84
HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006. PLoS One (2012) 0.84
Urine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women. Int J Gynaecol Obstet (2013) 0.83
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening. J Clin Microbiol (2016) 0.82
Fixing Formalin: A Method to Recover Genomic-Scale DNA Sequence Data from Formalin-Fixed Museum Specimens Using High-Throughput Sequencing. PLoS One (2015) 0.82
Human Papilloma Viruses and Breast Cancer. Front Oncol (2015) 0.81
Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria. PLoS One (2016) 0.81
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study. BMC Cancer (2016) 0.81
Use of Sequenom sample ID Plus® SNP genotyping in identification of FFPE tumor samples. PLoS One (2014) 0.79
Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia. Front Oncol (2016) 0.79
Early Human Papilloma Virus (HPV) Oncogenic Influences in Breast Cancer. Breast Cancer (Auckl) (2015) 0.79
Human papillomavirus prevalence in invasive laryngeal cancer in the United States. PLoS One (2014) 0.79
Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples. J Clin Virol (2016) 0.78
Improvement of DNA extraction for human papillomavirus genotyping from formalin-fixed paraffin-embedded tissues. Biores Open Access (2012) 0.78
High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy. PLoS One (2013) 0.78
HPV genotypes detected in cervical cancers from Alaska Native women, 1980-2007. Int J Circumpolar Health (2013) 0.77
Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study. Virol J (2015) 0.77
Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark. Br J Cancer (2015) 0.76
Human papillomavirus genotypes distribution in cervical cancer cases in Gabon. Infect Agent Cancer (2016) 0.76
Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma. Cancer Cell Int (2016) 0.75
Detection and Genotyping of Human Papillomaviruses from Archival Formalin-Fixed Tissue Samples. Curr Protoc Microbiol (2016) 0.75
A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics. Clin Proteomics (2014) 0.75
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun (1985) 6.57
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol (1998) 5.29
The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when? PLoS One (2007) 3.27
DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem (2002) 2.16
Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression. Clin Chem (2010) 1.66
PCR analysis in archival postmortem tissues. Mol Pathol (2003) 1.53
RNA extracted from paraffin-embedded human tissues is amenable to analysis by PCR amplification. Biotechniques (1991) 1.48
Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays. J Clin Microbiol (2010) 1.18
Evaluation of DNA extraction methods and real time PCR optimization on formalin-fixed paraffin-embedded tissues. Asian Pac J Cancer Prev (2007) 1.13
Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples. J Clin Microbiol (2009) 1.03
An improved method for DNA extraction from paraffin sections. Pathol Res Pract (2001) 0.88
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis (2013) 6.04
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis (2002) 3.42
Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 2.73
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis (2009) 2.43
Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94
A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003) 1.80
The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med (2005) 1.78
Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol (2006) 1.75
Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol (2005) 1.67
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty. Cancer (2013) 1.64
Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol (2007) 1.60
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis (2003) 1.39
Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry (2006) 1.31
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 1.26
Post-licensure monitoring of HPV vaccine in the United States. Vaccine (2010) 1.24
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers (2002) 1.20
A real-time PCR assay for HPV52 detection and viral load quantification. Clin Lab (2012) 1.18
DNA and RNA references for qRT-PCR assays in exfoliated cervical cells. J Mol Diagn (2006) 1.15
Primary and secondary prevention of cervical cancer--opportunities and challenges. J Natl Cancer Inst (2009) 1.13
Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis (2012) 1.12
Human papillomavirus and molecular considerations for cancer risk. Cancer (2008) 1.12
Population impact of HPV vaccines: summary of early evidence. J Adolesc Health (2013) 1.12
Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? J Psychosom Res (2004) 1.12
Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact? J Infect Dis (2011) 1.11
Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome. J Transl Med (2003) 1.10
Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med (2008) 1.06
Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach. PLoS One (2012) 1.06
Seroprevalence of human papillomavirus type 16 in children. J Infect Dis (2005) 1.06
Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurol (2006) 1.05
CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep (2014) 1.05
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics (2006) 1.05
Type-specific reproducibility of the Roche linear array HPV genotyping test. J Clin Virol (2008) 1.04
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis (2014) 1.04
Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. Vaccine (2012) 1.03
Evaluation of the rapid BioStar optical immunoassay for detection of Chlamydia trachomatis in adolescent women. J Clin Microbiol (2008) 1.03
Gene expression correlates of unexplained fatigue. Pharmacogenomics (2006) 1.03
Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Methods (2006) 1.02
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis (2013) 1.02
National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2003) 1.02
Performance of commercial reverse line blot assays for human papillomavirus genotyping. J Clin Microbiol (2012) 1.01
Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol (2005) 1.00
Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis (2013) 0.99
Regional distribution of fatiguing illnesses in the United States: a pilot study. Popul Health Metr (2004) 0.98
Minimum data elements for research reports on CFS. Brain Behav Immun (2012) 0.96
Impact of RNA extraction from limited samples on microarray results. Biotechniques (2003) 0.95
Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. J Low Genit Tract Dis (2014) 0.94
Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association. Neuromolecular Med (2010) 0.94
Coping styles in people with chronic fatigue syndrome identified from the general population of Wichita, KS. J Psychosom Res (2006) 0.94
Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening. J Womens Health (Larchmt) (2013) 0.93
Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med (Berl) (2004) 0.93
Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol (2005) 0.92
Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery. BMC Genomics (2005) 0.92
Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009. Cancer Causes Control (2014) 0.92
Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstet Gynecol (2014) 0.91
Exploration of neuroendocrine and immune gene expression in peripheral blood mononuclear cells. Brain Res Mol Brain Res (2004) 0.91
Assessment of normal variability in peripheral blood gene expression. Dis Markers (2002) 0.91
Effect of storage temperatures on the stability of cytokines in cervical mucous. Cytokine (2007) 0.91
The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions. Cancer Causes Control (2011) 0.89
Bioelectronic DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogens. BMC Infect Dis (2003) 0.88
Characterization of the Human Cervical Mucous Proteome. Clin Proteomics (2010) 0.88
Optimization of SELDI-TOF protein profiling for analysis of cervical mucous. J Proteomics (2008) 0.88
Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994. Sex Transm Dis (2008) 0.87
Oral sampling and human papillomavirus genotyping in HIV-infected patients. J Oral Pathol Med (2011) 0.87
Identification of Phosphoglycerate Kinase 1 (PGK1) as a reference gene for quantitative gene expression measurements in human blood RNA. BMC Res Notes (2011) 0.87
Implementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis. BMC Genomics (2010) 0.87
Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States. Vaccine (2013) 0.87
Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study. BMC Neurol (2007) 0.87
HPV prevalence among women from Appalachia: results from the CARE project. PLoS One (2013) 0.86
Multiscale analysis of heart rate variability in non-stationary environments. Front Physiol (2013) 0.86
Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse. Pediatr Infect Dis J (2009) 0.85
Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia. J Virol Methods (2012) 0.85
Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2006) 0.85
Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy. Cancer Epidemiol Biomarkers Prev (2011) 0.85
Genital human papillomaviruses among women of reproductive age in Jamaica. Rev Panam Salud Publica (2013) 0.84
HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006. PLoS One (2012) 0.84
Human papillomavirus type 16 variant assignment by pyrosequencing. J Virol Methods (2006) 0.83
Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology (2011) 0.83
An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome. BMC Med (2009) 0.83
Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012. Emerg Infect Dis (2015) 0.83
International collaborative proficiency study of Human Papillomavirus type 16 serology. Vaccine (2011) 0.83
Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells. Cancer Epidemiol Biomarkers Prev (2007) 0.82
Exploration of statistical dependence between illness parameters using the entropy correlation coefficient. Pharmacogenomics (2006) 0.81
Human papillomavirus antibody reference reagents for use in postvaccination surveillance serology. Clin Vaccine Immunol (2012) 0.81
Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study. Gynecol Oncol (2005) 0.81
Differences and changes in human papillomavirus type 16 variant status in human immunodeficiency virus-positive adults are not uncommon. J Gen Virol (2010) 0.81
Analysis of 16S rRNA gene sequences and circulating cell-free DNA from plasma of chronic fatigue syndrome and non-fatigued subjects. BMC Microbiol (2002) 0.81